What can we learn from 2024’s biotech IPOs?

What can we learn from 2024’s biotech IPOs?

By Ayla Ellison, James Waldron – Fierce Biotech – After a promising start to the year, the biotech IPO market picked up steam again late this summer, with notable offerings from companies like Upstream, Septerna and BioAge. But what does this mean for the...